COPD
Remdesivir + Corticosteroids Boost Survival in COVID-19 Patients With COPD
Early initiation of remdesivir (Veklury, Gilead Sciences) and corticosteroids in patients with COPD and COVID-19 ...
AUGUST 8, 2025
Biologics Hit Multiple Targets in Asthma and COPD
The future of pulmonary medicine is rapidly evolving, with biologic therapies hitting multiple targets in asthma ...
OCTOBER 26, 2024
Higher Risk for Death From Flu Seen in COPD Patients
Because of the high risk, patients with COPD should get an annual flu shot, and if they become ill, should receive ...
FEBRUARY 4, 2019
FDA Approves Lonhala Magnair to Treat COPD
Glycopyrrolate inhalation solution is the first nebulized, long-acting muscarinic antagonist (LAMA) approved for ...
DECEMBER 8, 2017
Macrolides Reduce Readmission Rates for Acute Exacerbations of COPD
Macrolide antibiotics help delay hospital readmission and also might reduce costs, according to a new University of ...
MARCH 29, 2017
New COPD Drug Available
AstraZeneca announced that the Bevespi Aerosphere inhaler is now available.
JANUARY 11, 2017
Long-Term Oxygen Therapy for Mild COPD Questioned
Long-term home oxygen therapy offers little benefit for people with milder chronic obstructive pulmonary disease, a ...
NOVEMBER 10, 2016
